Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma-Reference-Cited by-同舟云学术

Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma

Published:2010-10 Issue:8 Volume:33 Page:828-833
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Royal Richard E.,Levy Catherine,Turner Keli,Mathur Aarti,Hughes Marybeth,Kammula Udai S.,Sherry Richard M.,Topalian Suzanne L.,Yang James C.,Lowy Israel,Rosenberg Steven A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference44 articles.

1. Cancer: Principles and Practice of Oncology. 8th ed;Royal,2008

2. National failure to operate on early stage pancreatic cancer;Bilimoria;Ann Surg,2007

3. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater–results of a controlled, prospective, randomised multicentre study;Bakkevold;Eur J Cancer,1993

4. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection;Kalser;Arch Surg,1985

5. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer;Neoptolemos;N Engl J Med,2004

Cited by 998 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapeutic strategies in hepatopancreatobiliary cancers;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. Cellular and molecular mechanisms of gastrointestinal cancer liver metastases and drug resistance;Drug Resistance Updates;2024-11

3. Identification of m6A modification patterns and RBM15 mediated macrophage phagocytosis in pancreatic cancer: An integrative analysis;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

4. Barriers and opportunities in pancreatic cancer immunotherapy;npj Precision Oncology;2024-09-12

5. Dendritic Cell–Based Immunotherapy in Patients With Resected Pancreatic Cancer;Journal of Clinical Oncology;2024-09-10